A trial found the allergy spray azelastine lowered COVID-19 infection risk. Users tested positive less often and later than those on placebo. Experts say larger studies are needed to confirm the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Azelastine lowered the risk for SARS-CoV-2 infection vs.

(WGN Radio) – An over-the-counter nasal spray for allergies could actually protect you from catching COVID, a recent randomized trial found. Using a nasal antihistamine that contains azelastine three ...

An over-the-counter nasal spray shows promise for preventing COVID-19, a new study found. The new study, published Tuesday in JAMA Internal Medicine, offered further evidence that azelastine may be a ...

(CNN) — Amid the uncertainty surrounding eligibility for and access to the latest Covid-19 vaccine, a new study has found that a common nasal spray could help prevent infection. This randomized ...

Almost all participants had been vaccinated against COVID-19. They were randomly assigned to receive either azelastine (0.1%) nasal spray or placebo. They used the spray three times a day for 56 days.

A world-first clinical trial has found that a simple daily nasal spray can significantly reduce the risk of COVID-19 in cancer patients, offering a potential new tool to protect vulnerable people from ...

Share on Pinterest A new trial shows that a common nasal spray may help lower the risk of contracting COVID-19 and other respiratory illnesses. Professional Studio Images/Getty Images Researchers say ...